Почетна › Рак бешике › Kalifornija
Kliničke studije za Рак бешике u državi Kalifornija
53 studija za Рак бешике traži učesnike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
- Los Angeles25 студија
- Baldwin Park14 студија
- San Francisco13 студија
- Orange12 студија
- San Diego11 студија
- Irvine11 студија
- Sacramento10 студија
- Torrance8 студија
- Santa Monica7 студија
- Bakersfield6 студија
- Mountain View5 студија
- Newport Beach5 студија
- Burbank3 студија
- Santa Maria3 студија
- Santa Barbara3 студија
- Alhambra3 студија
- Santa Rosa3 студија
- Long Beach3 студија
Zvanični tekst studije (na engleskom)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03866382A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Hoag Memorial Hospital Presbyterian ( Site 0814), Newport Beach
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07419295Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- Los Angeles General Medical Center, Los Angeles
- и још 2
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06770582The Vanguard Study: Testing a New Way to Screen for Cancer
- Kaiser Permanente-Division of Research, Pleasanton
- Naval Medical Center -San Diego, San Diego
Тражи се учесникЗдраве особе су добродошле
Узраст од 45 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06995898A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- City of Hope National Medical Center, Duarte
- City of Hope at Irvine Lennar, Irvine
- Administrative Address: UCLA Hematology/Oncology, Los Angeles
- и још 3
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07090499A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- City of Hope National Medical Center, Duarte
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 40 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05366881Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- и још 22
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06760819FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- City of Hope, Duarte
- University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
- University of California - Irvine, Orange
- и још 2
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05614739Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Tower Cancer Research Foundation, Beverly Hills
- City of Hope Corona, Corona
- City of Hope Comprehensive Cancer Center, Duarte
- и још 10
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07061964A Study of MGC026 in Participants With Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06242470Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07566156A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Tower Cancer Research Foundation, Beverly Hills
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UC San Diego Moores Cancer Center, La Jolla
- и још 7
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07097142Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
- City of Hope Medical Center, Duarte
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT05519878Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- UCLA Hematology/Oncology - Alhambra, Alhambra
- UCLA Hematology/Oncology - Atascadero, Atascadero
- UCLA Hematology/Oncology - Beverly Hills, Beverly Hills
- и још 39
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07421700A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
- TRIO-US (Translational Research in Oncology-US), Los Angeles
- UCLA Hematology/Oncology - Santa Monica, Los Angeles
- и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07218380Measuring Surgical Recovery After Radical Cystectomy
- Stanford University, Stanford
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT03193970Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Michael Oefelein Clinical Trials, Bakersfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07480356KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- UCSF Medical Center at Mission Bay ( Site 5044), San Francisco
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT07232602Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Michael G Oefelein Clinical Trials ( Site 0138), Bakersfield
- USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles
- Genesis Healthcare-Torrance ( Site 0140), Torrance
- и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06833073Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT07664397Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06470282A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Duarte, Duarte
- Providence Medical Foundation, Santa Rosa
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07277413DESTINY-PANTUMOUR04
- Research Site, San Diego
Тражи се учесникОпсервациона студија
Узраст од 18 до 130 · Оба пола · Ажурирано 25. 9. 2026. · NCT07124000A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- City of Hope, Duarte
- USC/Norris Comprehensive Cancer Center, Los Angeles
- UCSF Medical center Parnassus, San Francisco
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT07217171ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of California, San Diego, La Jolla
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Redwood City, Redwood City
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT05059444Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Michael G Oefelein, MD Clinical Trials, Bakersfield
- City of Hope, Irvine
- Genesis Research (Greater Los Angeles), Los Alamitos
- и још 6
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06567743Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Michael Oefelein Clinical Trials, Bakersfield
- University of California Irvine Medical Center, Orange
- Genesis Research LLC, Torrance
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 24. 8. 2026. · NCT05951179Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Research Site, Los Angeles
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT07129993Patient-Derived Xenografts to Reduce Cancer Health Disparities
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
- University of California Davis Comprehensive Cancer Center, Sacramento
Тражи се учесникОпсервациона студија
Узраст од 21 до 100 · Оба пола · Ажурирано 20. 8. 2026. · NCT04410302LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- University of California - Irvine Medical Center, Irvine
- UC San Diego Moores Cancer Center, La Jolla
- USC/Norris Comprehensive Cancer Center, Los Angeles
- и још 2
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 8. 2026. · NCT04752722Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Local Institution - 0162, Fullerton
- Palo Alto Center-Palo Alto Medical Foundation Research Institute, Palo Alto
- Sutter Health - Sutter Institute for Medical Research, Sacramento
- и још 3
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 29. 7. 2026. · NCT07106762A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
Тражи се учесникФаза 2
Узраст 8 и старији · Оба пола · Ажурирано 27. 7. 2026. · NCT05503797A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Kaiser Permanente Anaheim Kraemer Medical Offices, Anaheim
- Foothill Cardioology, Arcadia
- Kaiser Permanente Baldwin Park Medical Center, Baldwin Park
- и још 58
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT04879329An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, San Francisco
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT07720284Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 14. 7. 2026. · NCT06580002A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
- USC Norris Comprehensive Cancer Center, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07337525Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.